|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/47 | |
| A61K 31/337 | |||
| A61K 31/4745 | |||
| A61K 31/517 | |||
| A61K 31/7068 | |||
| A61K 45/00 | |||
| A61P 35/00 | |||
| A61K 31/4412 | |||
| A61K 31/513 | |||
| A61K 31/53 |
| (11) | Number of the document | 2799070 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12863476.3 |
| Date of filing the European patent application | 2012-12-27 | |
| (97) | Date of publication of the European application | 2014-11-05 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/JP2012/083794 |
| Date | 2012-12-27 |
| (87) | Number | WO 2013/100014 |
| Date | 2013-07-04 |
| (30) | Number | Date | Country code |
| 2011290125 | 2011-12-28 | JP |
| (72) |
FUJITA, Hidenori, JP
KATO, Masanori, JP
|
| (73) |
Taiho Pharmaceutical Co., Ltd.,
1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444,
JP
|
| (54) | EFFECT POTENTIATOR FOR ANTITUMOR AGENTS |
| EFFECT POTENTIATOR FOR ANTITUMOR AGENTS |